Management of Persistent Hyperglycemia After IV Regular Insulin

Initial Assessment and Management

For patients with persistent hyperglycemia after administering 10 units of regular insulin intravenously, the American College of Critical Care Medicine recommends continuing IV insulin infusion until blood glucose stabilizes below 180 mg/dL (10 mmol/L), then transitioning to a structured basal-bolus subcutaneous insulin regimen 1, 2
The American College of Critical Care Medicine suggests checking blood glucose levels immediately and monitoring frequently (every 30-60 minutes) while hyperglycemia persists 1, 2
The Anaesthesia society recommends assessing for potential causes of insulin resistance such as infection, stress, or medications that may be contributing to hyperglycemia 3
For critically ill patients, the American College of Critical Care Medicine recommends maintaining continuous IV insulin infusion with a target blood glucose range of 140-180 mg/dL (7.8-10.0 mmol/L) 1, 2
For non-critically ill patients with persistent hyperglycemia >180 mg/dL (10 mmol/L), the American College of Critical Care Medicine suggests continuing IV insulin infusion using a standardized protocol with explicit decision support tools 1, 2

The Anaesthesia society recommends using a nurse-driven protocol with variable rates based on glucose values to achieve target range 4
The Anaesthesia society suggests continuing IV insulin until blood glucose levels are stable (consistently <180 mg/dL or 10 mmol/L) for at least several hours 3, 4

The Anaesthesia society recommends calculating total daily insulin requirement based on the IV insulin used in the previous 24 hours 3, 4
The Anaesthesia society suggests administering long-acting basal insulin (e.g., glargine, detemir) immediately before discontinuing IV insulin 3
The Anaesthesia society recommends using the following formula for transition dosing:

The Anaesthesia society recommends administering basal insulin once daily (preferably in the evening around 8 PM) 3, 4
The Anaesthesia society suggests adding rapid-acting insulin before meals based on carbohydrate intake 3
The Anaesthesia society recommends including correction doses of rapid-acting insulin for persistent hyperglycemia 4

The Anaesthesia society recommends checking for ketosis if blood glucose remains >16.5 mmol/L (300 mg/dL) despite insulin therapy 4
The Anaesthesia society suggests considering ICU transfer for more aggressive IV insulin therapy if ketosis is present with blood glucose >16.5 mmol/L (300 mg/dL) 4

The Diabetes Care society recommends monitoring blood glucose every 4-6 hours after transitioning to subcutaneous insulin 5
The Diabetes Care society suggests adjusting insulin doses daily based on glucose patterns 5
The Diabetes Care society recommends planning for outpatient follow-up within 1-2 weeks of discharge for patients with significant hyperglycemia during hospitalization 5

The Anaesthesia society recommends never abruptly discontinuing IV insulin without overlapping with subcutaneous basal insulin, as this can lead to recurrent hyperglycemia 3, 4
The Diabetes Care society suggests avoiding relying solely on sliding-scale insulin, as basal-bolus regimens provide superior glycemic control 6
The American College of Critical Care Medicine recommends avoiding targeting overly strict glycemic control (<110 mg/dL or 6.1 mmol/L), as this increases hypoglycemia risk without improving outcomes 1